Connection

ARUN SREEKUMAR to Treatment Outcome

This is a "connection" page, showing publications ARUN SREEKUMAR has written about Treatment Outcome.
Connection Strength

0.007
  1. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009 Sep 24; 114(13):2733-43.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.